Why Selling Hikma Pharmaceuticals Plc, Taylor Wimpey plc And BG Group plc Today Could Be A Mistake

Should shareholders resist the temptation to sell Hikma Pharmaceuticals Plc (LON:HIK), Taylor Wimpey plc (LON:TW) and BG Group plc (LON:BG), asks Roland Head?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Knowing when to sell a share isn’t easy: you’re faced with the constant fear that your profits will gradually fall away if you wait too long — and that you’ll miss out on possible gains by selling too soon.

In this article, I’ll take a look at three shares that have come onto my sales radar recently — and explain why it might make sense to hold on a little longer.

Hikma Pharmaceuticals

Hikma Pharmaceuticals (LSE: HIK) has been the second-biggest faller in the FTSE 100 over the last month, falling by 10%. The firm’s shares are now down by 20% from their all-time high of 2,617p, in February.

Shareholders may well be tempted to sell now to lock in some profit and avoid any further falls, but I believe this short-term outlook could be a mistake.

Over the medium term, Hikma’s fundamental attractions appear intact. The firm reported an adjusted operating margin of 28.7% for 2014, broadly in-line with the 30.3% reported in 2013. Operating cash conversion remained strong, at 105% of operating profits, and after slipping slightly this year, earnings per share are expected to rise by 18% in 2016.

There’s also the possibility of a takeover bid, in the wake of several recent mergers and acquisitions in the pharmaceutical sector. While Hikma’s 2016 P/E of 18.6 isn’t cheap, it looks reasonable to me, and I’d be tempted to hold on for the long term.

Taylor Wimpey

Housebuilder Taylor Wimpey (LSE: TW) shot higher on Friday, in the wake of the Conservative election victory. Although I do believe housing stocks are likely to be close to their peaks, I reckon the housing market should continue to perform well, in the short term at least.

Land and labour costs have not yet risen out of hand, and housebuilders such as Taylor Wimpey currently seem to be in a sweet spot, delivering rising profits thanks to limited supply of and strong demand for new houses.

Taylor Wimpey shares offer a 2015 forecast yield of 5.4%, rising to 6.0% in 2016, backed by net cash and an operating margin which hit 18.5% last year.

I’d be tempted to hold on a little longer.

BG Group

The recent offer by Royal Dutch Shell for BG Group (LSE: BG) (NASDAQOTH: BRGYY.US) put a clear limit on the likely value of BG Group shares.

The only trouble is that the last seen price of 1,191p, BG shares currently trade almost 10% below the indicative value of Shell’s cash and share offer, which stands at 1,318p, based on a Shell share price of 2,100p.

The figures suggest that buying BG shares today could deliver a 10% profit when the Shell deal is completed. Of course, there are risks — the value of Shell’s shares could fall, and BG shareholder might even vote against the deal.

However, I suspect the deal will go through, and believe that a yield of almost 6% should help to support Shell’s share price. In my view, holding onto BG shares — or even buying more — could pay off.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of Royal Dutch Shell. The Motley Fool UK has recommended Hikma Pharmaceuticals. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »